ArticleClinicoEconomics and outcomes research : CEOR2020

Analysis of the Health and Budgetary Impact of Chondroitin Sulfate Prescription in the Treatment of Knee Osteoarthritis Compared to NSAIDs and COXIBs.

Carlos Rubio-Terrés et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.